Multidisciplinary care in pediatric oncology

Journal of Multidisciplinary Healthcare

Volumn 4, Issue , 2011, Pages 171-181

  Cantrell, Mary Ann ^a   Ruble, Kathy ^b  

^a VILLANOVA UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Childhood cancer; Leukemia

Indexed keywords

EID: 84864944614     PISSN: None     EISSN: 11782390     Source Type: Journal    
DOI: 10.2147/JMDH.S7108     Document Type: Article

References (69)

1. Hewitt M, Weiner SL, Simone JV, editors. Childhood Cancer Survivorship: Improving Care and Quality. Washington, DC: The National Academy Press; 2003.
2. Wolff JA. History of pediatric oncology. Pediatr Hematol Oncol. 1991;8:88–91.
3. Farber S. Chemotherapy in the treatment of leukemia and Wilms’ tumor. JAMA. 1966;198:826.
4. Wilbur JR. Combination chemotherapy for embryonal rhabdomyosarcoma. Cancer Chemother Rep. 1974;58(2):281–284.
5. Meadows AT. Pediatric cancer survivors: past history and future challenges. Available at: http://www.iom.edu/∼/media/Files/Activity%20Files/Disease/NCPF/BackgroundPaperPediatricCancerSurvivorsPastHistoryandFutureChallanges.pdf. Accessed April 28, 2011.
6. Djerassi I, Farber S, Abir E, Neikirk W. Continuous infusion of methotrexate in children with acute leukemia. Cancer. 1967;20: 233–242.
7. Aur RJA, Simone J, Hustu HO, et al. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood. 1971;37(3):272–281.
8. Aur RJA, Simone JV, Verzosa MS, Hustu HO, Pinkel DP, Barker LF. Leukoencephalopathy in children with acute lymphocytic leukemia receiving preventive central nervous system therapy [author’s translation]. Sangre (Barc). 1978;23:1–12.
9. Rubin CM, Le Beau MM, Mick R, et al. Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia. J Clin Oncol. 1991;9:2183–2192.
10. Borella L, Sen L. T cell surface markers on lymphoblasts from acute lymphocytic leukemia. J Immunol. 1973;111:1257–1260.
11. Dow LW, Borella L, Sen L, et al. Initial prognostic factors and lymphoblast- erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. Blood. 1977;50:671–682.
12. Crist WM, Pui CH. Clinical implications of cytogenetic and molecular analyses of pediatric acute lymphoblastic leukemia. Stem Cells. 1993; 11:81–87.
13. Jeha S, Pui CH. Risk-adapted treatment of pediatric acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23:973–990.
14. Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol. 2009;10: 82–93.
15. Abed R, Grimer R. Surgical modalities in the treatment of bone sarcoma in children. Cancer Treat Rev. 2010;36:342–347.
16. Rao BN, Tsuchida Y, Kaneko M, Spicer RD, Plaschkes J. The surgeon and the child with cancer: a report of the International Society of Pediatric Surgical Oncology (IPSO). Med Pediatr Oncol. 2000;34: 424–428.
17. American Academy of Pediatrics. Section on hematology/oncology. Policy statement on guidelines for pediatric cancer centers. Pediatrics. 2004;113(6):1833–1835.
18. American Academy of Pediatrics section statement: Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. Pediatrics. 2004;113:1833–1835.
19. Kellie SJ, Howard SC. Global child health priorities: what role for paediatric oncologists? Eur J Cancer. 2008;44:2388–2396.
20. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA. 2004;291:2471–2475.
21. Raab CP, Gartner JC. Diagnosis of childhood cancer. Prim Care. 2009; 36:671–684.
22. Carlson CA, Hobbie WL, Brogna M, Ginsberg JP. A multidisciplinary model of care for childhood cancer survivors with complex medical needs. J Pediatr Oncol Nurs. 2008;25:7–13.
23. Kurt BA, Armstrong GT, Cash DK, et al. Primary care management of the childhoood cancer survivor. J Pediatr. 2008;152:458–466.
24. Kline NE. Multidisciplinary care of the pediatric oncology patient. J Pediatr Oncol Nurs. 2005;22:193.
25. Tracey E, DiTaranto S, Womer R. Evolution of a rapid hydration protocol. J Pediatr Oncol Nurs. 2004;21:22–26.
26. Ruccione K, Hinds PS, Wallace JD, Kelly KP; Children’s Oncology Group Nursing Discipline. Creating a novel structure for nursing research in a cooperative clinical trials group: The Children’s Oncology Group experience. Semin Oncol Nurs. 2005;21(2):79–88.
27. Ruccione K, Kelly KP. State of the science: pediatric oncology nursing in cooperative clinical trials groups comes of age. Sem Oncol Nurs. 2000;16:253–260.
28. Hinds PS, Hockenberry M., Gattuso JS, et al. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer. 2007;15:2321–2330.
29. Reaman GH. Pediatric cancer research from past successes through collaboration to future transdisciplinary research. J Pediatr Oncol Nurs. 2004;21:123–127.
30. Ruccione K. The legacy of pediatric oncology nursing in advancing survivorship research and clinical care. J Pediatr Oncol Nurs. 2009;26: 255–265.
31. Pek JH, Chan YH, Yeoh AE, Quah TC, Tan PL, Aung L. Health-related quality of life in children with cancer undergoing treatment: a first look at the Singapore experience. Ann Acad Med Singapore. 2010;39: 43–48.
32. Eiser C. Beyond survival: quality of life and follow-up after childhood cancer. J Pediatr Psychol. 2007;32:1140–1150.
33. Reimers TS, Mortensen EL, Nysom K, Schmiegelow K. Health-related quality of life in long-term survivors of childhood brain tumors. Pediatr Blood Cancer. 2009;53:1086–1091.
34. Blaauwbroek R, Groenier KH, Kamps WA, Meyboom-de JB, Postma A. Late effects in adult survivors of childhood cancer: the need for life-long follow-up. Ann Oncol. 2007;18:1898–1902.
35. Meeske KA, Patel SK, Palmer SN, Nelson MB, Parow AM. Factors associated with health-related quality of life in pediatric cancer survivors. Pediatr Blood Cancer. 2007;49:298–305.
36. Reaman GH. Pediatric oncology: current views and outcomes. Pediatr Clin N Am. 2002;49:1305–1318.
37. Bertolone K. Pediatric oncology: past presnet, and new modlaities of treatment. J Intraven Nurs. 1997;20:136–140.
38. Ross JA, Olshan AF. Pediatric cancer in the United States: the Children’s Oncology Group epidemiology reaserch program. Cancer Epidemiol Biomarkers Prev. 2004;13(10):1552–1554.
39. Basu SK, Fernandez ID, Fisher SG, Asselin BL, Lyman GH. Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol. 2005;23:7958–7966.
40. Pasqualotto AC, Denning DW. New and emerging treatments for fungal infections. J Antimicrob Chemother. 2008;61(Suppl 1):i19–i30.
41. Araya CE, Lew JF, Fennell RS III, Neiberger RE, Dharnidharka VR. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant. 2006;10:32–37.
42. Orudjev E, Lange BJ. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol. 2002;39: 77–85.
43. Santolaya ME. Supportive care in children. Curr Opin Oncol. 2010;22: 323–329.
44. Hawkins J. Supportive care: managing febrile neutropenia. Paediatr Nurs. 2009;21:33–37.
45. Barton SJ, Chase T, Latham B, Rayens MK. Comparing two methods to obtain blood specimens from pediatric central venous catheters. J Pediatr Oncol Nurs. 2004;21:320–326.
46. Horvath B, Norville R, Lee D, Hyde A, Gregurich M, Hockenberry M. Reducing central venous catheter-related bloodstream infections in children with cancer. Oncol Nurs Forum. 2009;36:232–238.
47. Pinkerton CR, Williams D, Wootton C, Meller ST, McElwain TJ. 5-HT3 antagonist ondansetron–an effective outpatient antiemetic in cancer treatment. Arch Dis Child. 1990;65:822–825.
48. Hedstrom M, Haglund K, Skolin I, von EL. Distressing events for children and adolescents with cancer: child, parent, and nurse perceptions. J Pediatr Oncol Nurs. 2003;20:120–132.
49. Williams PD, Schmideskamp J, Ridder EL, Williams AR. Symptom monitoring and dependent care during cancer treatment in children: pilot study. Cancer Nurs. 2006;29:188–197.
50. Dupuis LL, Taddio A, Kerr EN, Kelly A, MacKeigan L. Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents. Pharmacotherapy. 2006;26: 1221–1231.
51. Linder LA. Measuring physical symptoms in children and adolescents with cancer. Cancer Nurs. 2005;28:16–26.
52. Phillips RS, Gopaul S, Gibson F, et al. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood. Cochrane Database Syst Rev. 2010:CD007786.
53. McGrath PA. Development of the World Health Organization guidelines on cancer pain relief and palliative care in children. J Pain Symptom Manage. 1996;12:87–92.
54. Geeta MG, Geetha P, Ajithkumar VT, Krishnakumar P, Kumar KS, Mathews L. Management of pain in leukemic children using the WHO analgesic ladder. Indian J Pediatr. 2010;77:665–668.
55. Zernikow B, Smale H, Michel E, Hasan C, Jorch N, Andler W. Paediatric cancer pain management using the WHO analgesic ladder–results of a prospective analysis from 2265 treatment days during a quality improvement study. Eur J Pain. 2006;10:587–595.
56. Post-White J, Sencer S, Fitzgerald M. Complementary and alternative treatments in children with cancer. In: Kelly K, Baggott C, Foley G, editors. Nursing Care of the Child with Cancer. 2nd ed. Philadelphia: Saunders; 2003:256–263.
57. Post-White J. Complementary and alternative medicine in pediatric oncology. J Pediatr Oncol Nurs. 2006;23:244–253.
58. Post-White J, Hawks R. Complementary and alternative medicine in pediatric oncology. Sem Oncol Nurs. 2005;21:107–114.
59. Wild MR, Espie CA. The efficacy of hypnosis in the reduction of procedural pain and distress in pediatric oncology: a systematic review. J Dev Behav Pediatr. 2004;25:207–213.
60. Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics. 2010;125:768–776.
61. Hawks R. Complementary and alternative medicine research initiatives in the Children’s Oncology Group and the role of the pediatric oncology nurse. J Pediatr Oncol Nurs. 2006;23:261–264.
62. Post-White J, Hawks R, O’Mara A, Ott MJ. Future directions of CAM research in pediatric oncology. J Pediatr Oncol Nurs. 2006;23: 265–268.
63. Zebrack B, Zeltzer L. Quality of life issues and cancer survivorship. Curr Probl Cancer. 2003;27:198–211.
64. Children’s Oncology Group. www.childrensoncologygroup.org/.
65. CureSearch. Children’s cancer information. Available at: http://www.curesearch.org/. Accessed April 28, 2011.
66. Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27: 2308–2318.
67. CureSearch. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Available at: http://www.childrensoncologygroup.org/disc/le/pdf/LTFUGuidelines.pdf. Accessed April 28, 2011.
68. Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J. Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Environ Health Perspect. 2002;110(7):721–728.
69. National Cancer Institute. A snapshot of pediatric cancers. Available at: http://www.cancer.gov/aboutnci/servingpeople/pediatric-snapshot.pdf. Accessed April 28, 2011.